Sophie Paget-Bailly is a research engineer in epidemiology and clinical research. She passed with honours the East of France inter-region master’s degree in public health and occupational and environmental risks. During the master’s degree’s internship in the Interregional Epidemiology Unit of Bourgogne/Franche-Comté, she realized a quantitative health risk assessment in the context of chemical contamination of groundwater. She defended a PhD in Public Health and Epidemiology in Paris XI University, Doctoral School 420, working in the Centre for Research in Epidemiology and Population Health in Villejuif, France. During her PhD, she worked on occupational exposures and head and neck cancer, providing two systematic reviews and meta-analyses and analyzing data from the ICARE case-control study. She was also representative of the PhD students at the ED420 school council.

She then joined the UMQVC at the University hospital of Besancon where she provides methodological support for clinicians in designing, analyzing and promoting results from clinical research. She is particularly involved into research on breast cancer or gynecologic cancers. She is statistical editor among the Cochrane Lung Cancer Group. She also provides lessons in biostatistics to medical school students and in research methodology to public health master’s degree students. Since 2017, she is the head of the module "Monitoring of HRQoL in clincial practice".

Main areas of expertise

  • Epidemiology
  • Clinical trials and clinical research
  • Biostatistics
  • Oncology
  • Meta-analyses and Cochrane methodology
  • Occupational epidemiology


Main ongoing external collaboration

- Cochrane Lung Cancer Group



Derniers articles

sample

AbstractHigh-risk HPV (hrHPV) testing has been implemented as a primary screening tool for cervical cancer in numerous...

Posté par : Dr. Sophie PAGET-BAILLY, Dr. Dewi VERNEREY, Mme. Aurélia MEURISSE, Mme. Julie HENRIQUES
Nom de la revue : Cancers (Basel)

sample

ABSTRACTBACKGROUND:Two main therapies, pazopanib and sunitinib, are used in the first-line settingfor metastatic renal...

Posté par : Pr. Franck BONNETAIN, Dr. Dewi VERNEREY, Mme. Aurélia MEURISSE, , Dr. Sophie PAGET-BAILLY, Mme. Joëlle FRITZSCH,
Nom de la revue : Health and Quality of Life Outcomes

sample

AbstractIntroduction - Routine Electronic Monitoring of Health-Related Quality of Life (HRQoL) (REMOQOL) in clinical...

Posté par : Dr. Sophie PAGET-BAILLY, , , Mme. Joëlle FRITZSCH, Mr. Antoine FALCOZ,
Nom de la revue : Quality of Life Research

AbstractBackground: Randomized controlled trials (RCTs) represent the best evidence in oncology research....

Posté par : Mr. Antoine FALCOZ, Dr. Sophie PAGET-BAILLY, Dr. Dewi VERNEREY
Nom de la revue : Neurooncol Pract

sample

AbstractBackground: The intensive care unit is increasingly recognized as a stressful environment for healthcare...

Posté par : Mme. Julie HENRIQUES, Dr. Sophie PAGET-BAILLY
Nom de la revue : Ann Intensive Care .

sample

AbstractBackground: In 2013, the interim analysis of the Protocol for Herceptin as Adjuvant therapy with Reduced...

Posté par : Dr. Sophie PAGET-BAILLY, Mme. Julie HENRIQUES
Nom de la revue : Lancet

sample

AbstractBackground: Ageing is associated with an increased prevalence of comorbidities and sarcopenia as well as a...

Posté par : Dr. Sophie PAGET-BAILLY
Nom de la revue : BMJ Open

sample

AbstractBackground: Sleep apnea (SA) was reported as possibly exacerbating symptoms of COVID-19, a disease induced...

Posté par : Mme. Aurélia MEURISSE, Dr. Sophie PAGET-BAILLY
Nom de la revue : Nature and Science of Sleep

sample

Background: Despite its proven efficacy in reducing recurrence and improving survival, adherence to endocrine...

Posté par : Dr. Sophie PAGET-BAILLY
Nom de la revue : Trials

sample

ABSTRACTBackground: Cardiac toxicity with a decrease of the left ventricular ejection fraction (LVEF) is the main side...

Posté par : Mme. Julie HENRIQUES, Dr. Sophie PAGET-BAILLY
Nom de la revue : The Breast

Dernières actualités

Derniers outils

The management of locally advanced pancreatic cancer (LAPC) patients remains controversial. Better discrimination for...

Posté par : Pr. Franck BONNETAIN, Dr. Sophie PAGET-BAILLY, Dr. Dewi VERNEREY

Découvrez la présentation du Pr Bonnetain dans le cadre du séminaire du Cancéropôle Ile de France sur les tumeurs...

Posté par : Dr. Sophie PAGET-BAILLY, Pr. Franck BONNETAIN

Posté par : Mme. Joëlle FRITZSCH, , Dr. Sophie PAGET-BAILLY

Posté par : Dr. Sophie PAGET-BAILLY

Le vendredi 17 novembre a eu lieu au PCBio du CHU de Besançon le séminaire Qualité de Vie en Cancérologie, organisé...

Posté par : Dr. Sophie PAGET-BAILLY, , Mme. Joëlle FRITZSCH

2015-2024 © Copyright - UMQVC.org

Website by Pearlweb